1. A chitosan/acellular matrix-based neural graft carrying mesenchymal stem cells to promote peripheral nerve repair.
- Author
-
Zhang Z, Li M, Cheng G, Wang P, Zhou C, Liu Y, Duan X, Wang J, Xie F, Zhu Y, and Zhang J
- Subjects
- Animals, Rats, Male, Extracellular Matrix metabolism, Peripheral Nerves, Mesenchymal Stem Cells cytology, Mesenchymal Stem Cells metabolism, Chitosan chemistry, Rats, Sprague-Dawley, Nerve Regeneration, Mesenchymal Stem Cell Transplantation methods, Sciatic Nerve, Peripheral Nerve Injuries therapy
- Abstract
Background: Treatment of peripheral nerve defects is a major concern in regenerative medicine. This study therefore aimed to explore the efficacy of a neural graft constructed using adipose mesenchymal stem cells (ADSC), acellular microtissues (MTs), and chitosan in the treatment of peripheral nerve defects., Methods: Stem cell therapy with acellular MTs provided a suitable microenvironment for axonal regeneration, and compensated for the lack of repair cells in the neural ducts of male 8-week-old Sprague Dawley rats., Results: In vitro, acellular MTs retained the intrinsic extracellular matrix and improved the narrow microstructure of acellular nerves, thereby enhancing cell functionality. In vivo neuroelectrophysiological studies, gait analysis, and sciatic nerve histology demonstrated the regenerative effects of active acellular MT. The Chitosan + Acellular-MT + ADSC group exhibited superior myelin sheath quality and improved neurological and motor function recovery., Conclusions: Active acellular-MTs precellularized with ADSC hold promise as a safe and effective clinical treatment method for peripheral nerve defects., Competing Interests: Declarations. Ethics approval and consent to participate: Title of the approved project: Nerve defect animal model(SD rats). Name of the institutional approval committee: the Ethics Committee of the Chinese PLA General Hospital. Approval number: SQ2022437. Date of approval: 2022-04-03. (2)Title of the approved project: Preparation of acellular nerves(SD rats). Name of the institutional approval committee: the Ethics Committee of the Chinese PLA General Hospital. Approval number:2022-X18-37. Date of approval:2022-01-08. In this study, all animal experiments were carried out following the guidelines and regulations related to the care and use of laboratory animals presented by the animal ethics committee of the Chinese PLA General Hospital (Code No.2022-X18-37). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF